These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33472499)

  • 1. The Impact of the Indonesian Chronic Disease Management Program (PROLANIS) on Metabolic Control and Renal Function of Type 2 Diabetes Mellitus Patients in Primary Care Setting.
    Alkaff FF; Illavi F; Salamah S; Setiyawati W; Ramadhani R; Purwantini E; Tahapary DL
    J Prim Care Community Health; 2021; 12():2150132720984409. PubMed ID: 33472499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of the Indonesian Chronic Disease Management Program (PROLANIS) in Patients with Hypertension During the COVID-19 Pandemic in Rural Areas: A Preliminary Evaluation Study.
    Salamah S; Khafiyya AN; Ramadhani R; Arfiana MR; Syamsuri I; Faizah NN; Nugraha D; Arifin B; Alkaff FF
    Med Sci Monit; 2023 May; 29():e939797. PubMed ID: 37170483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review.
    Rachmawati S; Prihhastuti-Puspitasari H; Zairina E
    J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31860469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implementation of community-based diabetes and hypertension management care program in Indonesia.
    Khoe LC; Wangge G; Soewondo P; Tahapary DL; Widyahening IS
    PLoS One; 2020; 15(1):e0227806. PubMed ID: 31935256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of the Quality of Life of Prolanis Hypertension Patients in Sixteen Primary Healthcare Centers in Pandeglang District, Banten Province, Indonesia, Using EQ-5D-5L Instrument.
    Yusransyah ; Halimah E; Suwantika AA
    Patient Prefer Adherence; 2020; 14():1103-1109. PubMed ID: 32753850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmacist counseling on health-related quality of life of patients with type 2 diabetes mellitus: a cluster randomized controlled study.
    Fajriansyah ; Iskandarsyah A; Puspitasari IM; Lestari K
    J Diabetes Metab Disord; 2020 Dec; 19(2):675-682. PubMed ID: 33520795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges of Shifting Diabetes Mellitus Care From Secondary- to Primary-Level Care in Urban and Rural Districts: A Qualitative Inquiry Among Health Providers.
    Putri LP; Mawarni D; Trisnantoro L
    J Prim Care Community Health; 2020; 11():2150132720924214. PubMed ID: 32517534
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of an intelligent chronic disease management system on patients with type 2 diabetes mellitus in a Beijing community.
    Xue-Juan W; Hao W; Cai-Ying G; Xin-Ying L; Hong-Yan J; Li W; Xiao-Ling G; Wan-Ying L; Wen-Juan G; Wan-Nian L
    BMC Health Serv Res; 2018 Oct; 18(1):821. PubMed ID: 30373577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.
    Lim LL; Lau ESH; Fu AWC; Ray S; Hung YJ; Tan ATB; Chamnan P; Sheu WHH; Chawla MS; Chia YC; Chuang LM; Nguyen DC; Sosale A; Saboo BD; Phadke U; Kesavadev J; Goh SY; Gera N; Huyen Vu TT; Ma RCW; Lau V; Luk AOY; Kong APS; Chan JCN;
    JAMA Netw Open; 2021 Apr; 4(4):e217557. PubMed ID: 33929522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus.
    Cui R; Qi Z; Zhou L; Li Z; Li Q; Zhang J
    Clin Interv Aging; 2016; 11():445-52. PubMed ID: 27143868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-management based coaching program to improve diabetes mellitus self-management practice and metabolic markers among uncontrolled type 2 diabetes mellitus in Indonesia: A quasi-experimental study.
    Pamungkas RA; Chamroonsawasdi K
    Diabetes Metab Syndr; 2020; 14(1):53-61. PubMed ID: 31887715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between blood uric acid and the incidence and progression of type 2 diabetes nephropathy.
    Li GX; Jiao XH; Cheng XB
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):506-511. PubMed ID: 29424910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology.
    Christ E; Czock A; Renström F; Ammeter T; Ebrahimi F; Zechmann S; Kutz A; Diem P; Häuptle C; Brändle M
    Swiss Med Wkly; 2022 Jul; 152():w30197. PubMed ID: 35925612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical and biochemical variables in type 2 diabetes mellitus patients and their first-degree relatives with metabolic syndrome in Benin City, Nigeria: A cross sectional case controlled study.
    Ogedengbe S; Ezeani IU; Aihanuwa E
    Endocr Regul; 2016 Jan; 50(1):32-40. PubMed ID: 27560635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
    Sherrill CH; Pentecost A; Wood EE
    J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 diabetes mellitus.
    Salinero-Fort MA; Carrillo-de Santa Pau E; Arrieta-Blanco FJ; Abanades-Herranz JC; Martín-Madrazo C; Rodés-Soldevila B; de Burgos-Lunar C
    BMC Public Health; 2011 Apr; 11():267. PubMed ID: 21524316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Pharmacist Intervention on Medication Adherence and Clinical Outcomes of Type 2 Diabetes Mellitus Outpatients in Primary Healthcare in Indonesia.
    Besemah NA; Sartika RAD; Sauriasari R
    J Res Pharm Pract; 2020; 9(4):186-195. PubMed ID: 33912501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Weight Change, Clinical Outcomes, and Health Care Costs in Patients with Type 2 Diabetes.
    Mukherjee J; Sternhufvud C; Smith N; Bell K; Stott-Miller M; McMorrow D; Johnston S
    J Manag Care Spec Pharm; 2016 May; 22(5):449-66. PubMed ID: 27123909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicodemographic Profile and Outcomes of Type 2 Diabetes Mellitus in the Indonesian Cohort of DISCOVER: A 3-Year Prospective Cohort Study.
    Soeatmadji DW; Rosandi R; Saraswati MR; Sibarani RP; Tarigan WO
    J ASEAN Fed Endocr Soc; 2023; 38(1):68-74. PubMed ID: 37252407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.